Cannabis consumers are souring on Trump's weed record as rescheduling drags
Approval of the administration's cannabis moves fell to 29% among consumers in legal states, down from 48% last quarter and 73% the quarter before.
The rescheduling bump is wearing off. In a NuggMD and Marijuana Moment poll of 654 cannabis consumers in legal states, taken October 8-15, just 29% approve or strongly approve of the Trump administration's cannabis actions. That's down from 48% last quarter and 73% two quarters ago. For perspective, it was 6% in late 2025, before the rescheduling executive order.
Most consumers aren't angry, they're checked out: 51% are neutral and 20% disapprove. Approval splits by party, with 46% of Republicans approving versus 18% of Democrats and 26% of unaffiliated consumers.
The drop lines up with the calendar. Medical marijuana got its Schedule III order in April, but the broader rescheduling case has been frozen since late September over a GAO report. Nearly half of consumers (47%) said they'd be more supportive if the administration fully legalized cannabis.
Why it matters: Two weeks before the midterms, the White House's weed goodwill with actual cannabis users has been cut by more than half in six months.
